The Deubiquitinase Inhibitor b-AP15 and Its Effect on Phenotype and Function of Monocyte-Derived Dendritic Cells

The ubiquitin-proteasome system is elementary for cellular protein degradation and gained rising attention as a new target for cancer therapy due to promising clinical trials with bortezomib, the first-in class proteasome inhibitor meanwhile approved for multiple myeloma and mantle cell lymphoma. Bo...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmidt, Moritz, Altdörfer, Vanessa, Schnitte, Sarah, Fuchs, Alexander Rolf, Kropp, Korbinian Nepomuk, Maurer, Stefanie, Müller, Martin Rudolf, Salih, Helmut Rainer, Rittig, Susanne Malaika, Grünebach, Frank, Dörfel, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2019
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6538843/
https://www.ncbi.nlm.nih.gov/pubmed/31132676
http://dx.doi.org/10.1016/j.neo.2019.03.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6538843/
https://www.ncbi.nlm.nih.gov/pubmed/31132676
http://dx.doi.org/10.1016/j.neo.2019.03.001

Ejemplares similares